DOI: http://dx.doi.org/10.18203/2320-1770.ijrcog20205264

Conservative management of placenta percreta

Yogita Gavit, Deepika Sharma

Abstract


The incidence of placenta accreta, increta, percreta, collectively called placenta accrete spectrum disorders, has been rising dramatically over the last decade worldwide, mainly due to rising cesarean delivery rate. Antenatal diagnosis and making no attempt to remove any parts of placenta is associated with reduced levels of hemorrhage and therefore less blood transfusion. Although elective cesarean hysterectomy is the standard practice, the choice of conservative management has emerged into practice. Conservation of the uterus reduces numerous short- and long-term complications including massive blood transfusion, disseminated intravascular coagulopathy, high morbidity and mortality rates, adjacent pelvic organ damage, infection as well as long term psychological sequelae, due to loss of femininity and fertility. Hereby representing a model for the follow up of conservative management of placenta percreta. Sequential changes in symphysial fundal height, serum beta-HCG and ultrasonographic volume of the placenta mass were used as combined methods for the follow up of the case. The placental volume was calculated by using a 2-dimensional ultrasound scan by measuring the maximum length and anteroposterior and transverse diameters of the uterus and using the formula for the volume of prolate ellipsoid.  


Keywords


Placenta percreta, Conservative management

Full Text:

PDF

References


Committee on Obstetrics Practice, “ACOG committee opinion Placenta accrete Number 266, Januray 2002. America College of Obstetrics & Gynecologists. Int J Gynecol Obstet. 2002;1:77-8.

Tikkanen M, Paavonen J, Loukovaara M, Stefanovic V. Antenatal diagnosis of placenta accreta leads to reduced blood loss. Acta obstetricia et gynecologica Scandinavica. 2011;90(10):1140-6.

Hunt JC. Conservative management of placenta accreta in a multiparous woman. J Preg. 20100;2010.

Ghosh M, Chandraharan E. Management of post-partum haemorrhage. Obstet Gynaecol Reproduct Medic. 2017;27(8):239-44.

Gupta D, Sinha R. management of placenta accrete with oral Methotrexate. Int J Gynaecol Obstet. 1998; 60:171-3.

Kirkinen P, Dudenhausen J, Baumann H, Huch R. Postpartum blood flow velocity waveforms of the uetrine arteries . J Reprod Med. 1998;33:745-8.

Flam F, Kalstrom FP-OP, Carlsson B, Saroff L. Methotrexate for retained placental tissue. Eur Obstet Gynecol Reprod Biol. 1999;83:127-9.

Fox KA, Shamshirsaz AA, Carusi D, Secord AA, Lee P, Turan OM, et al. Conservative management of morbidly adherent placenta: expert review. Am J Obstet Gynecol. 2015;213(6):755-60.

Clausen C, Lönn L, Langhoff‐Roos J. Management of placenta percreta: a review of published cases. Acta obstetricia et gynecologica Scandinavica. 2014;93(2):138-43.

Hayes E, Ayida G, Crocker A. The morbidly adherent placenta: diagnosis and management options. Cur Opin Obstet Gynecol. 2011;23(6):448-53.

Royal College of Obstetricians and Gynaecologists, “Green-top Guideline No. 27. Placenta praevia, placenta praevia accreta and vasa praevia: diagnosis and management,” RCOG, London, 2011.

Roulot A, Barranger E, Morel O, Soyer P, Héquet D. Apport de l’échographique 2D/3D dans le suivi de l’élimination du résidu placentaire après traitement conservateur de placenta accreta. J Obstet Gynecol Biol Reproduct. 2015;44(2):176-83.

Matsumura N, Inoue T, Fukuoka M, Sagawa N, Fujii S. Changes in the serum levels of human chorionic gonadotropin and the pulsatility index of uterine arteries during conservative management of retained adherent placenta. J Obstet Gynaecol Res. 2000;26(2):81-7.

Jain A, Sepulveda W, Paterson-Brown S. Conservative management of major placenta previa accreta: three case reports. J Obstet Gynaecol. 2004;24(1):S63.